PANAVIR AMPOULES 0,004% 5ML
PANAVIR AMPOULES 0,004% 5ML - 1 pc
Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
Active substance: Panavir&№174; (purified extract of shoots of the plant Solanum tuberosum, the main active ingredient is a hexose glycoside consisting of glucose, rhamnose, arabinose, mannose, xylose, galactose, uronic acids) - 0.2 mg.
Excipients: 0.9% sodium chloride solution
Mechanism of action
PANAVIR is an antiviral and immunomodulatory agent. Increases the body’s non-specific resistance to various infections and contributes to the induction of Interferon.
Indications and usage
Herpes virus infections of various localization (including recurrent genital herpes, herpes Zoster and ophthalmic herpes).
Secondary immunodeficiency states on the background of infectious diseases.
Cytomegalovirus infection in patients with recurrent miscarriage. It can be used in women with chronic viral infection and interferon deficiency at the stage of preparation for pregnancy.
Human papillomavirus infection (anogenital warts) in complex therapy.
Panavir&№174; is used in the treatment of tick-borne encephalitis in order to reduce viral load and relieve neurological symptoms (anisoreflexia, reduced reflexes, painful exit points of the cranial nerves, nystagmus) in complex therapy.
Panavir&№174; is used in the complex treatment of immunocompromised patients with rheumatoid arthritis to enhance the analgesic and anti-inflammatory effect of concomitant therapy for herpes virus infection.
Individual intolerance. Panavir&№174; should not be used in patients in the event of an allergy to the components of the drug: glucose, mannose, rhinosis, arabinose, xylose.
Patients with severe pathology of the kidneys and spleen.
Lactation period, children up to 12 years.
Pregnancy and Breastfeeding
Use during pregnancy is possible only when the intended benefit to the mother outweighs the potential risk to the fetus.
If necessary, the use of the drug during lactation should stop breastfeeding.
Dosage and administration
Panavir&№174; in solution is used for intravenous administration of a therapeutic dose of 200 μg (the contents of one ampoule or vial) of the active substance.
For the treatment of herpes virus infections and tick-borne encephalitis, Panavir&№174; is used twice with an interval of 48 or 24 hours. If necessary, a month later the course of treatment can be repeated.
For the treatment of cytomegalovirus and human papillomavirus infections, Panavir&№174; is used three times in the first week with an interval of 48 hours and twice in the second week with an interval of 72 hours.
For herpes infection in patients with rheumatoid arthritis 5 injections with an interval of 24-48 hours, if necessary, repeat the course after 2 months.
Panavir&№174; should be injected slowly.
Overdose may be a reversible violation of the functions of the kidneys and spleen.
At a temperature not higher than 25? С.